Skip to content
Open access · OA via OpenAlex

Advances in mesenchymal stem cell-mediated gene therapy for cancer

Róisín M. Dwyer, Sonja Khan, Frank Barry, Timothy O’Brien, Michael Joseph Kerin

Stem Cell Research & Therapy · 2010 · ▲ 115 citations

Abstract

Mesenchymal stem cells have a natural tropism for tumours and their metastases, and are also considered immunoprivileged. This remarkable combination of properties has formed the basis for many studies investigating their potential as tumour-specific delivery vehicles for suicide genes, oncolytic viruses and secreted therapeutic proteins. The aim of the present review is to discuss the range of approaches that have been used to exploit the tumour-homing capacity of mesenchymal stem cells for gene delivery, and to highlight advances required to realize the full potential of this promising approach.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1186/scrt25
Canonical
link ↗
Fetched
2026-10-31 MST

Cite this

APA
Dwyer, R.M., Khan, S., Barry, F., O’Brien, T., &amp; Kerin, M.J. (2010). Advances in mesenchymal stem cell-mediated gene therapy for cancer. <em>Stem Cell Research & Therapy</em>. https://doi.org/10.1186/scrt25
Vancouver
Dwyer RM, Khan S, Barry F, O’Brien T, Kerin MJ. Advances in mesenchymal stem cell-mediated gene therapy for cancer. Stem Cell Research & Therapy. 2010. doi:10.1186/scrt25.
BibTeX
@article{risn2010Advanc, title = {Advances in mesenchymal stem cell-mediated gene therapy for cancer}, author = {Róisín M. Dwyer and Sonja Khan and Frank Barry and Timothy O’Brien and Michael Joseph Kerin}, journal = {Stem Cell Research & Therapy}, year = {2010}, doi = {10.1186/scrt25}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings